Martin, M. <br/><br/>
Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumad in patients with HER2-positive locally advanced or metastatic breast cancer: results from A phase IB / 
LLa study 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Cancer<br/>Cáncer de Mama<br/>Metastatic<br/>Metastásico